Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease

Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease

Abstract Background Kawasaki disease (KD) is usually treated with high-dose intravenous immunoglobulin (IVIg) as severe infectious and other diseases. Due to issues that are associated with immunoglobulin preparation, such as the risk of possible contamination by infectious agents and limited blood...

Full description

Bibliographic Details
Main Authors: Fuyu Ito, Toshiaki Oharaseki, Daisuke Tsukui, Yoshitaka Kimura, Tamiko Yanagida, Fukuko Kishi, Yoshio Yamakawa, Yosuke Kameoka, Shoichi Suzuki, Kazuko Uno, Osamu Suzuki, Noriko N. Miura, Naohito Ohno, Kei Takahashi, Hajime Kono, Kazuo Suzuki
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Kawasaki disease
Anti-apolipoprotein A-2
Vasculitis
Coronary arteritis
Online Access:https://doi.org/10.1186/s12969-022-00783-7

Internet

https://doi.org/10.1186/s12969-022-00783-7

Similar Items